Aptose Biosciences (APTO) Stock Highlights

0.98 | -15.52%

2024-06-01 04:39:30

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. Luxeptinib, its panFMS-like tyrosine kinase 3 / pan-Brutons tyrosine kinase inhibitor, is enrolling patients in a Phase 1, multicenter, open label, dose-escalation study with expansions to assess the safety, tolerability, PK, and preliminary efficacy of CG-806 in patients with chronic lymphocytic leukemia (CLL/SLL) or non-Hodgkin lymphomas (NHL). HM43239 is an oral potent myeloid kinome inhibitor, targeting a constellation of kinases operative in myeloid malignancies.

Statistics

Range Today

0.98 1.1

Volume Today 244.9K

Range 1 Year

0.39 6.6

Volume 1 Year 17.4M

Range 3 Year

0.36 6.6

Volume 3 Year 316.97M

Range 10 Year

0.36 9.25

Volume 10 Year 1.23B

Highlights

Market Capitalization 15.9M (micro)

Floating Shares 12.53M

Current Price 0.98

Price To Earnings -0.17

Earnings Per Share -6.09

Payout Ratio 0%

Performance

Latest -15.52%

1 Month -20.33%

3 Months -46.45%

6 Months -59.17%

1 Year +122.73%

3 Years -81.68%

5 Years -50.25%

10 Years -80.56%

Benchmarks

Market Capitalization

313 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

291 / 368

Free Cashflow

155 / 352

Performance 5 years

189 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.